The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 337:1010-1011 October 2, 1997 Number 14
NextNext

Elevated Serum Thyrotropin in Thyroxine-Treated Patients with Hypothyroidism Given Sertraline

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: Patients with hypothyroidism and organic depression may need both levothyroxine and antidepressant drug therapy. In nine levothyroxine-treated patients with hypothyroidism (Patients 1 through 9) who were treated with sertraline (Zoloft, Pfizer), we found elevated serum thyrotropin concentrations, indicative of a decrease in the efficacy of levothyroxine (Table 1). In addition, in two other levothyroxine-treated patients with thyroid cancer whose serum thyrotropin concentrations had been deliberately suppressed (Patients 10 and 11), the values rose into the normal range during sertraline therapy. The value for the serum free thyroxine index decreased in all patients in whom it . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.